37278
Current Page: Home   >  People   >  Guo Long
Guo Long POST-DOCTOR     start: 2025

Education

2013.9-2018.6: Bachelor of Medical Science, University of South China

2018.9-2021.6: Master of Medical Science, liver surgery of Xiangya hospital, Central South University

2021.9-2025.6: Doctor of Medical Science, liver surgery of Xiangya hospital, Central South University

 


Work Experience

2025.9–Present: Post-doctor, Xiangya Hospital, Central South University



Research Interests

Hepatocellular carcinoma, intrahepatic cholangiocarcinoma, liver metastatic carcinoma



Publications

(1)       Long G, Wang D, Tang J, Hu K, Zhou L. USP8 promotes the tumorigenesis of intrahepatic cholangiocarcinoma via stabilizing OGT. Cancer Cell Int. 2024 Jul 7;24(1):238. doi: 10.1186/s12935-024-03370-w. PMID: 38973004

(2)       Long G, Wu Z, Wang D, Mi X, Hu K, Zhou L, Tang J. UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells. Free Radic Biol Med. 2024 Feb 20;212:162-173. doi: 10.1016/j.freeradbiomed.2023.11.030.. PMID: 38092274.

(3)       Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, Zhou L, Tao Y. Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT. Adv Sci (Weinh). 2023 Nov;10(33):e2302953. doi: 10.1002/advs.202302953. Epub 2023 Oct 22. PMID: 37867237.

 

 

Email:lg1357820157@163.com